Welcome to LookChem.com Sign In|Join Free

CAS

  • or
5-(m-Methoxyphenyl)valeric acid, also known as 5-MVA, is a chemical compound with the molecular formula C12H16O3. It is a derivative of valeric acid, a straight-chain carboxylic acid, featuring a valeric acid core with a methoxyphenyl group attached to the third carbon atom. 5-(m-Methoxyphenyl)valeric acid has garnered research interest due to its potential biological activities, such as antioxidant properties and roles in treating neurodegenerative diseases. Moreover, 5-MVA serves as a precursor in the synthesis of pharmaceuticals and agrochemicals and has been investigated for its anti-inflammatory and anti-cancer capabilities, positioning it as a promising candidate for further pharmacological studies.

6500-64-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 6500-64-7 Structure
  • Basic information

    1. Product Name: 5-(m-Methoxyphenyl)valeric acid
    2. Synonyms: 3-Methoxybenzenepentanoic acid;5-(3-Methoxyphenyl)pentanoic acid;5-(m-Methoxyphenyl)valeric acid
    3. CAS NO:6500-64-7
    4. Molecular Formula: C12H16O3
    5. Molecular Weight: 208
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 6500-64-7.mol
  • Chemical Properties

    1. Melting Point: 54-57℃
    2. Boiling Point: 371℃
    3. Flash Point: 142℃
    4. Appearance: /
    5. Density: 1.093
    6. Refractive Index: N/A
    7. Storage Temp.: Sealed in dry,Room Temperature
    8. Solubility: N/A
    9. PKA: 4.75±0.10(Predicted)
    10. CAS DataBase Reference: 5-(m-Methoxyphenyl)valeric acid(CAS DataBase Reference)
    11. NIST Chemistry Reference: 5-(m-Methoxyphenyl)valeric acid(6500-64-7)
    12. EPA Substance Registry System: 5-(m-Methoxyphenyl)valeric acid(6500-64-7)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 6500-64-7(Hazardous Substances Data)

6500-64-7 Usage

Uses

Used in Pharmaceutical Industry:
5-(m-Methoxyphenyl)valeric acid is used as a precursor in the synthesis of various pharmaceuticals for its potential role in the development of new drugs targeting neurodegenerative diseases, inflammation, and cancer.
Used in Agrochemical Industry:
5-MVA is utilized as a starting material in the production of agrochemicals, contributing to the creation of compounds that can enhance crop protection and yield.
Used in Antioxidant Applications:
5-(m-Methoxyphenyl)valeric acid is employed as an antioxidant agent, potentially protecting cells from oxidative stress and damage, which is crucial in the prevention and treatment of various diseases and conditions.
Used in Neurodegenerative Disease Treatment:
5-MVA is used as a therapeutic agent in the treatment of neurodegenerative diseases, leveraging its potential neuroprotective properties to slow down or halt the progression of these conditions.
Used in Anti-Inflammatory and Anti-Cancer Research:
5-(m-Methoxyphenyl)valeric acid is used as a subject of pharmacological research for its anti-inflammatory and anti-cancer properties, with the aim of discovering new treatment options for inflammatory conditions and various types of cancer.

Check Digit Verification of cas no

The CAS Registry Mumber 6500-64-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,5,0 and 0 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 6500-64:
(6*6)+(5*5)+(4*0)+(3*0)+(2*6)+(1*4)=77
77 % 10 = 7
So 6500-64-7 is a valid CAS Registry Number.

6500-64-7Relevant articles and documents

ACYL HYDRAZONE LINKERS, METHODS AND USES THEREOF

-

Paragraph 00238, (2019/07/04)

The present application is directed to compounds of Formula (I)-(VI): (I), (II), (III), (IV), (V) (VI), (VII) and (VIII), compositions comprising these compounds and their uses, for example as medicaments and/or diagnostics.

A 2 - methoxy - 6, 7, 8, 9 - tetrahydrobenz cyclohepta - 5 - ketone (by machine translation)

-

Paragraph 0048; 0052; 0053, (2018/03/24)

The invention discloses a method for synthesizing 2 - methoxy - 6, 7, 8, 9 - tetrahydrobenz cyclohepta - 5 - one method, its steps are: halogen anisole with glutaric anhydride reaction for the preparation of 5 - (3 - methoxyphenyl) - 5 - oxo-valeric acid, reducing 5 - (3 - methoxyphenyl) - 5 - oxo-valeric acid for the preparation of 5 - (3 - methoxyphenyl) pentanoic acid; 5 - (3 - methoxyphenyl) pentanoic acid through the intramolecular Friedel-crafts acylation reaction to obtain 2 - methoxy - 6, 7, 8, 9 - tetrahydrobenz cyclohepta - 5 - one. The method of the invention the synthesis step is short, low cost, the total yield is high, can be used for industrial production. (by machine translation)

Hydrogen Bonded Phenol-Quinolines with Highly Controlled Proton-Transfer Coordinate

Parada, Giovanny A.,Glover, Starla D.,Orthaber, Andreas,Hammarstr?m, Leif,Ott, Sascha

, p. 3365 - 3372 (2016/07/23)

A series of polycyclic phenols with intramolecular hydrogen bonds (IMHB) to quinolines was synthesized by Friedl?nder annulation of cycloalkanone-functionalized anisoles with 2-aminobenzaldehyde. The prepared compounds represent the first series of IMHB phenols in which the substitution and conjugation patterns between the phenols and the hydrogen bond acceptors are kept constant, and in which comparable electronic interaction between the two subunits is thus ensured. The distance and relative orientation between the phenolic OH and the quinolone nitrogen atom is controlled by 1,3-cycloalkadienes of different ring sizes to which the phenol and quinoline subunits are formally annulated.1H δ(OH) chemical shift and X-ray crystal structure characterization support the conclusion that the size and conformational preference of the 1,3-cycloalkadiene rings control the H-bond geometry and strength. As a result, the oxygen to nitrogen distances differ by as much as 0.30 ? across the series.

Structural interrogation of benzosuberene-based inhibitors of tubulin polymerization

Herdman, Christine A.,Devkota, Laxman,Lin, Chen-Ming,Niu, Haichan,Strecker, Tracy E.,Lopez, Ramona,Liu, Li,George, Clinton S.,Tanpure, Rajendra P.,Hamel, Ernest,Chaplin, David J.,Mason, Ralph P.,Trawick, Mary Lynn,Pinney, Kevin G.

, p. 7497 - 7520 (2015/12/18)

The discovery of 3-methoxy-9-(3′,4′,5′-trimethoxyphenyl)-6,7-dihydro-5H-benzo[7]annulen-4-ol (a benzosuberene-based analogue referred to as KGP18) was originally inspired by the natural products colchicine and combretastatin A-4 (CA4). The relative struct

The total synthesis of hypodematine

Kang, Zhi-Yun,Zhang, Qing-Jian,Chen, Ruo-Yun,Zhang, Pei-Cheng,Yu, De-Quan

, p. 840 - 848 (2013/09/23)

Hypodematine, isolated from Hypodematium sinense Iwatsuki as an alkaloid with a new skeleton, was synthesized via nine reaction steps, in which the synthesis of 2-aryl-1-benzazocines via Beckmann rearrangement of 5H-benzocyclohepten-5-one oxime mesylate i

A photo-favorskii ring contraction reaction: The effect of ring size

Kammath, Viju Balachandran,?olomek, Tomá?,Ngoy, Bokolombe Pitchou,Heger, Dominik,Klán, Petr,Rubina, Marina,Givens, Richard S.

, p. 1718 - 1729 (2013/03/29)

The effect of ring size on the photo-Favorskii induced ring-contraction reaction of the hydroxybenzocycloalkanonyl acetate and mesylate esters (7a-d, 8a-c) has provided new insight into the mechanism of the rearrangement. By monotonically decreasing the ring size in these cyclic derivatives, the increasing ring strain imposed on the formation of the elusive bicyclic spirocyclopropanone 20 results in a divergence away from rearrangement and toward solvolysis. Cycloalkanones of seven or eight carbons undergo a highly efficient photo-Favorskii rearrangement with ring contraction paralleling the photochemistry of p-hydroxyphenacyl esters. In contrast, the five-carbon ring does not rearrange but is diverted to the photosolvolysis channel avoiding the increased strain energy that would accompany the formation of the spirobicyclic ketone, the "Favorskii intermediate 20". The six-carbon analogue demonstrates the bifurcation in reaction channels, yielding a solvent-sensitive mixture of both. Employing a combination of time-resolved absorption measurements, quantum yield determinations, isotopic labeling, and solvent variation studies coupled with theoretical treatment, a more comprehensive mechanistic description of the rearrangement has emerged.

Efficient Method for Preparing Functionalized Benzosuberenes

-

Page/Page column 16, (2012/06/01)

The disclosed process can efficiently synthesize functionalized benzosuberenes. The process provides an improved method of production of benzosuberene and compounds containing a benzosuberene moiety, which is characterized by a ring closing methodology comprising reaction of a 5-phenylpentanoic acid with Eaton's reagent to form the benzosuberone. The process, optionally, further includes steps for adding a functional group at the ketone position.

An amino-benzosuberene analogue that inhibits tubulin assembly and demonstrates remarkable cytotoxicity

Tanpure, Rajendra P.,George, Clinton S.,Sriram, Madhavi,Strecker, Tracy E.,Tidmore, Justin K.,Hamel, Ernest,Charlton-Sevcik, Amanda K.,Chaplin, David J.,Trawick, Mary Lynn,Pinney, Kevin G.

supporting information, p. 720 - 724 (2013/11/06)

The recent discovery of a small-molecule benzosuberene-based phenol that demonstrates remarkable picomolar cytotoxicity against selected human cancer cell lines and strongly inhibits tubulin polymerization (1-2 μM) inspired the design and synthesis of a variety of new, structurally diverse benzosuberene derivatives. An efficient synthetic route to functionalized benzosuberenes was developed. This methodology utilized a Wittig reaction, followed by a selective alkene reduction and ring-closing cyclization to form the core benzosuberone structure. This synthetic route facilitated the preparation of a 4-nitro-1-(3′,4′,5′-trimethoxyphenyl) benzosuberene derivative and its corresponding 4-amino analogue in good yield. The 4-amino analogue was a strong inhibitor of tubulin polymerization (1.2 μM), demonstrated enhanced cytotoxicity against the human cancer cell lines examined (GI50 = 33 pM against SK-OV-3 ovarian cancer, for example), and exhibited a concentration dependent disruption of a pre-established capillary-like network of tubules formed from human umbilical vein endothelial cells.

FUSED TETRACYCLE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

-

Page/Page column 115, (2012/05/04)

The present invention relates to novel Fused Tetracycle Derivatives of Formula (I): and pharmaceutically acceptable salts thereof, wherein A, A', B, G, R1, U, V, W, W', X, X', Y and Y' are as defined herein. The present invention also relates to compositions comprising at least one Fused Tetracycle Derivative, and methods of using the Fused Tetracycle Derivatives for treating or preventing HCV infection in a patient.

PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS

-

, (2008/12/07)

The present invention provides phenylalkylcarboxylic acid compounds and compositions containing such compounds which facilitate the delivery of biologically active agents.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 6500-64-7